Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PA172059

Invitrogen™ Cytonectin Polyclonal Antibody
GREENER_CHOICE

Catalog No. PA172059
Change view
Click to view available options
Quantity:
10 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PA172059 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PA172059 Supplier Invitrogen™ Supplier No. PA172059
Add to Cart
Add to Cart

Description

Chicken Polyclonal Antibody

PA1-72059 detects Cytonectin in human samples. PA1-72059 has been successfully used in Western blot procedures. Antibody is diluted to a 1 mg/mLstock solution. This is diluted 1:1000 immediately prior to blot application. The PA1-72059 immunogen is from cytonectin isolated from a cell lysate of normal human third trimester placenta by ROOGE.

TRUSTED_SUSTAINABILITY

Specifications

Antigen Cytonectin
Applications Western Blot
Classification Polyclonal
Concentration 20 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.05% sodium azide; pH 7.2
Host Species Chicken
Immunogen Cytonectin isolated from a cell lysate of normal human third trimester placenta by ROOGE.
Purification Method IgY fraction
Quantity 10 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgY
Show More Show Less

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.